NCT04732962

Brief Summary

Osteoarthritis (OA), the most common type of arthritis, affects more than 32.5 million adults in the United States. It is also among the most expensive condition to treat when joint replacement surgery is required. Although biomechanics plays an important role in OA disease, the non-surgical treatment options addressing biomechanics are scarce with limited effect. AposHealth is the fist biomechanical treatment that was shown to have a significant short-term effect on patients with knee OA. The main objectives of this study are:

  1. 1.To assess AposHealth, a non-invasive home-based biomechanical treatment, as an alternative treatment for patients who are eligible for Total Knee Replacement (TKR).
  2. 2.To assess AposHealth as a new post-operative rehabilitation tool for patients post TKR.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

2 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 26, 2021

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 1, 2021

Completed
6 months until next milestone

Study Start

First participant enrolled

July 22, 2021

Completed
4.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2026

Completed
Last Updated

April 30, 2025

Status Verified

September 1, 2024

Enrollment Period

4.6 years

First QC Date

January 26, 2021

Last Update Submit

April 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • pain: Numerical Pain Rating Scale

    score range: worst 0 - 10 best

    12 months

Secondary Outcomes (10)

  • Veterans RAND 12 Health Survey (VR-12) physical component score

    3, 6, and 12 months

  • Koos Jr

    3, 6, and 12 months

  • pain: Numerical Pain Rating Scale

    3 and 6 months

  • Step length (left and right)

    6 and 12 months

  • Single limb support (SLS): % gait cycle (left and right)

    6 and 12 months

  • +5 more secondary outcomes

Study Arms (3)

AposHealth

EXPERIMENTAL

Following the initial consultation and calibration of the Apos device in the clinic, the patients will receive from his therapist a home-based treatment plan. This usually includes wearing the device for about 20 minutes with about 20% of weight-bearing (patient is instructed to wear the Apos and just be with the device and go about his/her daily routine). A gradual increase in usage time is prescribed reaching up to 60 min wear time with about 40% weight-bearing. Patients are requested to return to follow-up (FU) appointments after 1, 3, 6, 9 and 12 months. In addition, patients will have a remote FU after 1-week to confirm they use AposHealth as advised. During the follow-up appointment, re-assessment of clinical outcomes and gait patterns are performed and the calibration of the Apos device is adjusted as needed. The treatment plan is adjusted, and patients are encouraged to continue to wear the device regularly at home.

Device: AposHealth

Total Knee Replacement (TKR)

ACTIVE COMPARATOR

Patients will undergo TKR according to Geisinger's policy, guidelines and care protocol. The study baseline visit will occur 6 weeks postoperative for TKR groups.

Procedure: Total Knee Replacement (TKR)

Post TKR traditional physical therapy (PT) and AposHealth

EXPERIMENTAL

Patients who have had a knee replacement and were assigned to the traditional PT+ AposHealth group will follow Geisinger post-operative rehab protocol and will also receive AposHealth and follow the rehabilitation protocol. AposHealth will start six weeks post-op and will continue for 12 months. Patients will receive AposHealth similar to the non-invasive group, i.e., will have an initial evaluation (IE) and calibration of the Apos device, have a remote FU after one week from IE and in-clinic FUs at 1, 3 6, 9 and 12 months.

Device: AposHealthProcedure: Total Knee Replacement (TKR)

Interventions

AposHealth is comprised of a unique footwear (Apos device) and uses two convex pods called "Pertupods", which are screwed into the plantar surface of the sole so that a person walks on these pods. A trained Apos therapist calibrates the devices. The location of the pods is adjusted according to the treatment methodology, depending on the needed effect on unloading the knee and with the purpose of potentially alleviating pain immediately.

AposHealthPost TKR traditional physical therapy (PT) and AposHealth

A total knee replacement occurs when a diseased or damaged knee joint is totally replaced with an artificial joint called an implant. The implant consists of high-grade metal and plastic components that fuse to the resurfaced bone. It is designed to move like a healthy human joint.

Post TKR traditional physical therapy (PT) and AposHealthTotal Knee Replacement (TKR)

Eligibility Criteria

Age45 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Men or non-pregnant women
  • Between ages 45 and 80, inclusive
  • ACR clinical criteria for OA of the knee
  • Symptomatic uni- or bilateral OA of the knee for at least six months
  • Radiological criteria: X-rays showing tibiofemoral knee osteoarthritis defined as at least Kellgren and Lawrence Grade 2
  • At least a moderate NPRS pain score at baseline (≥5)
  • Score of 1-3 based on the American Society of Anesthesiologists Physical Status Classification System
  • Willing and able to read, comprehend, and sign the study informed consent form in English prior to study specific procedure

You may not qualify if:

  • Body Mass Index (BMI) \> 40
  • History of an inflammatory rheumatic disease
  • Non-knee musculoskeletal pain that is more severe than the knee pain
  • Corticosteroids injections in the knees in the previous 6 weeks
  • Previous major surgery to the knee such as osteotomy, hemiprosthesis, unilateral total joint replacement excluding knee arthroscopy \> 6 months
  • Patients with Geisinger Health Plan insurance for whom Apos is a covered treatment
  • Patients with a recent history (\<3 months) of a mental health condition, such as depression or anxiety
  • Problems with balance (\>2 unexplained falls within the last 12 months; experiencing regular dizziness that has caused a trip or fall; using a walking aid to get around such as a rollator, cane, walker)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Geisinger Medical Center

Danville, Pennsylvania, 17822, United States

RECRUITING

Geisinger - Orthopaedics Wilkes-Barre

Wilkes-Barre, Pennsylvania, 18702, United States

RECRUITING

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Arthroplasty, Replacement, Knee

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

Arthroplasty, ReplacementArthroplastyOrthopedic ProceduresSurgical Procedures, OperativePlastic Surgery ProceduresProsthesis Implantation

Study Officials

  • Michael Suk, MD

    Geisinger Clinic

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor and Chair, Musculoskeletal Institute & Department of Orthopaedic Surgery

Study Record Dates

First Submitted

January 26, 2021

First Posted

February 1, 2021

Study Start

July 22, 2021

Primary Completion

March 1, 2026

Study Completion

March 1, 2026

Last Updated

April 30, 2025

Record last verified: 2024-09

Data Sharing

IPD Sharing
Will not share

Locations